Shutterstock
Q&A: Investing in Life Science
Following the DVPs first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing. Read more
15 Apr 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
Chris Sutherland
Scotland’s Life Sciences Sector Poised for Growth
Speaking at an event in Edinburgh, Chris Dougray, Head of Development at CBRE Scotland, and Chris Williams, CBRE’s Head of Life Sciences, joined forces to examine the burgeoning sector’s place in Scotland. Read more
14 Mar 2024
Pharmaceutical Insights + Pharma Finance and Investment Insights
UK biotech company responds to approval changes and R&D tax relief
Last Thursday, chancellor Jeremy Hunt announced new measures for smoother medicine approvals in the UK, increased support for R&D, and a simplified tax system for SMEs. UK biotech company, Nevrargenics shared its position on the 2023 Budget. Read more
23 Mar 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Vitalii Stock Shutterstock
Why invest in pharma in times of a recession?
Léone Atayi, CEO of Hybrigenics and Stemcis, discusses the importance of investing in the pharmaceutical industry amid a recession. Read more
21 Feb 2023
Pharmaceutical Insights + Pharma Finance and Investment Insights
Smart Financing and CROs: investing in digitalisation for drug development
Sally-Anne Whybrow, healthcare business development manager, Siemens Financial Services, UK examines how smart financing can help CROs invest in financially-sustainable technology. Read more
5 Oct 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Q&A with Lonza: Support for biotech startups
Following on from their recent partnership with Israel Biotech Fund (IBF), EPM caught up with Lonza's Pnina Weitz on the importance of early-stage support for emerging companies, and how robust strategies early on can pave a way to commercialisation. Read more
29 Jun 2022
Pharmaceutical Insights + Pharma Finance and Investment Insights
Mer_Studio Shutterstock
Concinnity Genetics raises £3m
Concinnity Genetics, an Edinburgh-based gene control company, has announced the closure of its oversubscribed £3m seed funding round. Read more
19 Dec 2024
Pharma Manufacturing News + Pharma Finance and Investment News
tech_BG Shutterstock
Noema Pharma extends Series B financing round
Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced the close of a Series B extension financing round with an investment from EQT Life Sciences. Read more
17 Dec 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Pixel Alchemy/Adobe Stock
Starget Pharma secures $5.1 million investment for targeted cancer therapy
ARC Innovation announced the successful $5.1 million funding round of Starget Pharma, a startup specialising in precise cancer diagnosis and targeted radiotherapy. Read more
5 Nov 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Portescap
How are drive systems for wearable and automatic drug delivery devices are central to the patient outcome?
Portescap’s business development manager for medical applications, Dave Beckstoffer, explains how drive systems for wearable and automatic drug delivery devices are central to the patient outcome. Read more
19 Dec 2024
Trong Nguyen Shutterstock
Securing the chain: The critical role of supply chain management in pharmaceutical packaging
Roel Winter, supply chain manager, Tjoapack discusses the critical role of supply chain management in pharmaceutical packaging. Read more
17 Dec 2024
ArisGlobal
Regulatory AI appetites are growing
ArisGlobal’s director of product management’s Agnes Cwienczek, reports on AI-boosted regulatory process automation and other top-level findings from a new Censuswide survey of senior life sciences regulatory professionals. Read more
16 Dec 2024
Purolite
Q&A: Purolite's Felix Solamo
We caught up with Purolite's Felix Solamo to look back on Bio International 2024 and what it meant for the company. Read more
13 Dec 2024
A9 STUDIO Shutterstock
How ready are you? Annex 1 and the impact of primary packaging
While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe. Read more
12 Dec 2024
Bruker Microbiology
Advanced microbial ID system accelerates product release testing
Stefan Karl, CEO, Mikrobiologisches Prüflabor, Innsbruck and Olaf Degen, director industry microbiology, Bruker Microbiology & Infection Diagnostics discuss how advanced microbial ID systems accelerate product release testing. Read more
10 Dec 2024
